Chemokine expression is upregulated in chondrocytes in diabetic fracture healing.
暂无分享,去创建一个
Thomas A Einhorn | Chen Tian | D. Graves | R. Kayal | M. Siqueira | Jazia A. Alblowi | T. Einhorn | L. Gerstenfeld | Jazia Alblowi | Michelle F Siqueira | Rayyan A Kayal | Erin McKenzie | Yugal Behl | Louis Gerstenfeld | Dana T Graves | Chen Tian | Erin McKenzie | Y. Behl | Jazia A Alblowi | Michelle F. Siqueira
[1] John M. Ashton,et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. , 2011, Blood.
[2] M. Goldring,et al. Inflammation in osteoarthritis , 2011, Current opinion in rheumatology.
[3] S. Colucci,et al. Osteoclastogenesis and arthritis , 2011, Clinical and Experimental Medicine.
[4] G. Garlet,et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. , 2010, Bone.
[5] Thomas A Einhorn,et al. TNF-α Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] Thomas A Einhorn,et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. , 2009, The American journal of pathology.
[7] D. Graves,et al. Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. , 2009, Bone.
[8] S. Davies,et al. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. , 2008, Osteoarthritis and cartilage.
[9] Arata Nakajima,et al. Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. , 2008, Bone.
[10] S. Colla,et al. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. , 2008, Cancer research.
[11] M. Thomassen,et al. Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis , 2007, British journal of haematology.
[12] D. Graves,et al. Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] G. Garlet,et al. Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease , 2007, Journal of dental research.
[14] F. Canovas,et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes , 2007, Arthritis research & therapy.
[15] K. Jepsen,et al. Three-dimensional Reconstruction of Fracture Callus Morphogenesis , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[16] Gabriel S. Eichler,et al. Analysis of fracture healing by large-scale transcriptional profile identified temporal relationships between metalloproteinase and ADAMTS mRNA expression. , 2006, Matrix biology : journal of the International Society for Matrix Biology.
[17] C. Selinger,et al. MCP-1-induced Human Osteoclast-like Cells Are Tartrate-resistant Acid Phosphatase, NFATc1, and Calcitonin Receptor-positive but Require Receptor Activator of NFκB Ligand for Bone Resorption* , 2006, Journal of Biological Chemistry.
[18] T. Einhorn,et al. Application of Histomorphometric Methods to the Study of Bone Repair , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] Frank Beier,et al. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. , 2005, Molecular biology of the cell.
[20] W. Maloney,et al. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. , 2005, Bone.
[21] P. Tak,et al. The role of chemokines in rheumatoid arthritis and osteoarthritis , 2005, Scandinavian journal of rheumatology.
[22] G. Lisignoli,et al. CXCL12 chemokine up‐regulates bone resorption and MMP‐9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients , 2004, Journal of cellular physiology.
[23] D. Graves,et al. Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .
[24] L. Suva,et al. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. , 2003, Bone.
[25] K. Moriyama,et al. Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma , 2002 .
[26] W. Sellers,et al. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. , 2002, Cancer cell.
[27] K. Nagata,et al. The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP-1, MIP-1α, MIP-1β, IP-10)-positive cells in human periapical granulomas , 2001 .
[28] G. Roodman,et al. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. , 2001, Blood.
[29] R. Borzì,et al. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis , 1999, FEBS letters.
[30] G. Roodman. Mechanisms of bone lesions in multiple myeloma and lymphoma , 1997, Cancer.
[31] M. Burdick,et al. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. , 1995, The Journal of clinical investigation.
[32] R. Loder,et al. The influence of diabetes mellitus on the healing of closed fractures. , 1988, Clinical orthopaedics and related research.
[33] A. Hirschman,et al. Retardation of fracture healing in experimental diabetes. , 1968, The Journal of surgical research.
[34] A. Koch,et al. Chemokines and chemokine receptors in arthritis. , 2010, Frontiers in bioscience.
[35] A. Mantovani,et al. Chemokines and chemokine receptors: an overview. , 2009, Frontiers in bioscience.
[36] R. Borzì,et al. Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis. , 2003, Rheumatology.
[37] T A Einhorn,et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] K. Moriyama,et al. Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. , 2002, Blood.
[39] K. Nagata,et al. The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas. , 2001, Cytokine.